Nantahala Capital Management, LLC
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Nantahala Capital Management, LLC reported 107 stock positions worth $1.0 billion. Its top holding was Soleno Therapeutics (SLNO) at 10.2% of the portfolio, followed by Establishment Labs (ESTA, 9.9%) and Pathward Financial (CASH, 5.1%). Compared with Q4 2023, it opened 19 new positions, sold out of 18, added to 22 and reduced 37. The biggest buy was DXP Enterprises (DXPE, shares +34%) and the biggest sale an exit from iShares Russell 2000 ETF (IWM).
- Most Recent 13F
- Q2 2026
- Location
- NEW CANAAN, CT
- CIK
- 0001472322
- Portfolio Value
- $1.0B (Q1 2024)
- SEC Filing
- 0001104659-24-062060 ↗ filed May 15, 2024
Holdings Value
Holdings 107 stocks · $1.0B
| SLNO Soleno Therapeutics Inc. | 10.18% | 2,410,379 | $103.2M | Reduce -15.6% |
| ESTA Establishment Labs Holdings | 9.87% | 1,964,562 | $100.0M | Reduce -20.5% |
| CASH Pathward Financial Inc. | 5.09% | 1,021,727 | $51.6M | Reduce -3.6% |
| EOLS Evolus Inc. | 4.02% | 2,910,849 | $40.8M | No change |
| IMAX Imax Corp. | 3.52% | 2,203,177 | $35.6M | Reduce -8.5% |
| HGV Hilton Grand Vacations Inc. | 3.12% | 668,871 | $31.6M | Reduce -0.3% |
| BVS Bioventus Inc. Class A | 2.98% | 5,806,012 | $30.2M | Reduce -2.9% |
| RDNW Ridenow Group Inc. filed as RUMBLEON INC | 2.82% | 4,416,506 | $28.5M | No change |
| PTON Peloton Interactive Inc. Class A | 2.67% | 6,312,939 | $27.1M | Add +93.5% |
| RDVT Red Violet Inc. | 2.15% | 1,116,249 | $21.8M | Reduce -7.4% |
| CRMT America's Car-Mart Inc. | 1.97% | 312,128 | $19.9M | No change |
| KROS Keros Therapeutics Inc. | 1.92% | 293,997 | $19.5M | Reduce -5.2% |
| LYRA Lyra Therapeutics Inc. | 1.73% | 2,820,982 | $17.5M | Reduce -30.4% |
| ABEO Abeona Therapeutics Inc. | 1.65% | 2,310,640 | $16.8M | Add +2.7% |
| QURE Uniqure NV | 1.58% | 3,088,082 | $16.1M | Add +4.4% |
| TRML Tourmaline Bio Inc. | 1.58% | 700,907 | $16.1M | Add +70.6% |
| AMRX Amneal Pharmaceuticals Inc. | 1.57% | 2,619,943 | $15.9M | Add +12.2% |
| CDXS Codexis Inc. | 1.54% | 4,461,878 | $15.6M | Reduce -2.9% |
| VMD Viemed Healthcare Inc. | 1.44% | 1,550,122 | $14.6M | Reduce -20.6% |
| DXPE DXP Enterprises Inc. | 1.43% | 269,806 | $14.5M | Add +33.7% |
| ABVX Abivax SA-ADR | 1.43% | 1,010,034 | $14.4M | No change |
| ZVRA Zevra Therapeutics Inc. | 1.40% | 2,453,405 | $14.2M | No change |
| DYN Dyne Therapeutics Inc. | 1.22% | 435,256 | $12.4M | Reduce -32.3% |
| RSVR Reservoir Media Inc. | 1.21% | 1,550,797 | $12.3M | No change |
| EHTH Ehealth Inc. | 1.14% | 1,911,821 | $11.5M | Add +92.8% |
| SNDX Syndax Pharmaceuticals Inc. | 1.09% | 465,259 | $11.1M | Add +27.4% |
| AURA Aura Biosciences Inc. | 1.02% | 1,321,860 | $10.4M | No change |
| NPCE Neuropace Inc. | 1.01% | 778,260 | $10.3M | Reduce -33.7% |
| GDEN Golden Entertainment Inc. | 0.98% | 269,267 | $9.9M | Reduce -7.6% |
| ASSERTIO HOLDINGS INC | 0.88% | 9,270,836 | $8.9M | Add +21.7% |
| PAYO Payoneer Global Inc. | 0.87% | 1,821,426 | $8.9M | Add +4.2% |
| SVRA Savara Inc. | 0.85% | 1,737,410 | $8.7M | Add +75.9% |
| UNICYCIVE THERAPEUTICS INC | 0.85% | 3,335,586 | $8.6M | Reduce -3.0% |
| RMR RMR Group Inc./the - A | 0.82% | 345,792 | $8.3M | Reduce -14.4% |
| IMTX Immatics NV | 0.82% | 787,974 | $8.3M | Reduce -44.3% |
| ILPT Industrial Logistics Propert | 0.80% | 1,881,132 | $8.1M | Reduce -5.6% |
| VTGN Vistagen Therapeutics Inc. | 0.79% | 1,517,696 | $8.0M | Reduce -16.5% |
| RZLT Rezolute Inc. | 0.76% | 3,022,947 | $7.7M | Add +96.6% |
| NDLS Noodles & Co. | 0.76% | 4,033,329 | $7.7M | Add +7.7% |
| CLRB Cellectar Biosciences Inc. | 0.74% | 1,873,325 | $7.5M | Add +38.7% |
| LXFR Luxfer Holdings PLC | 0.70% | 685,253 | $7.1M | Reduce -62.1% |
| NNBR NN Inc. | 0.66% | 1,406,446 | $6.7M | Reduce -0.1% |
| EGRX Eagle Pharmaceuticals Inc. | 0.65% | 1,258,762 | $6.6M | New |
| RDI Reading International Inc. Class A | 0.61% | 3,385,253 | $6.2M | Reduce -0.5% |
| TELA Tela Bio Inc. | 0.61% | 1,097,866 | $6.2M | No change |
| ZYXIQ Zynex Inc. | 0.60% | 490,000 | $6.1M | Add +308.3% |
| CONNQ Conn's Inc. | 0.59% | 1,769,997 | $5.9M | Add +392.5% |
| TARS Tarsus Pharmaceuticals Inc. | 0.54% | 150,321 | $5.5M | Reduce -59.9% |
| COGT Cogent Biosciences Inc. | 0.52% | 790,936 | $5.3M | Add +23.4% |
| ALTG Alta Equipment Group Inc. | 0.51% | 402,509 | $5.2M | Add +33.1% |
| ELUT Elutia Inc. | 0.51% | 1,650,000 | $5.2M | No change |
| AGS Playags Inc. | 0.50% | 566,588 | $5.1M | No change |
| DHX Dhi Group Inc. | 0.49% | 1,966,417 | $5.0M | Reduce -25.5% |
| NSPR Inspiremd Inc. | 0.48% | 2,066,456 | $4.9M | No change |
| XTNT Xtant Medical Holdings Inc. | 0.46% | 4,000,000 | $4.7M | No change |
| ENVA Enova International Inc. | 0.45% | 71,865 | $4.5M | No change |
| THTX Theratechnologies Inc. | 0.44% | 2,682,228 | $4.5M | No change |
| SLN Silence Therapeutics PLC-ADR | 0.43% | 200,000 | $4.3M | New |
| MLYS Mineralys Therapeutics Inc. | 0.42% | 332,506 | $4.3M | New |
| VNDA Vanda Pharmaceuticals Inc. | 0.41% | 1,013,251 | $4.2M | No change |
| NAMS Newamsterdam Pharma Co. NV | 0.41% | 175,000 | $4.1M | New |
| DRIO Dariohealth Corp. | 0.40% | 2,632,559 | $4.0M | Add +12.7% |
| XBI SS SPDR S&P Biotech ETF | 0.39% | 42,069 | $4.0M | New |
| NGNE Neurogene Inc. | 0.36% | 72,279 | $3.7M | No change |
| OPTINOSE INC | 0.36% | 2,474,296 | $3.6M | Reduce -21.4% |
| AYTU Aytu Biopharma Inc. | 0.33% | 1,086,812 | $3.3M | No change |
| MIST Milestone Pharmaceuticals Inc. | 0.31% | 1,750,000 | $3.1M | New |
| STKS One Group Hospitality Inc. filed as THE ONE GROUP HOSPITALITY IN | 0.30% | 547,710 | $3.1M | New |
| MAX Mediaalpha Inc. Class A | 0.30% | 149,371 | $3.0M | Reduce -17.4% |
| ACHV Achieve Life Sciences Inc. | 0.29% | 654,000 | $3.0M | New |
| GAIA Gaia Inc. | 0.28% | 915,029 | $2.8M | No change |
| NVNO Envveno Medical Corporation | 0.27% | 495,736 | $2.7M | Reduce -29.8% |
| AEROVATE THERAPEUTICS INC | 0.27% | 91,188 | $2.7M | No change |
| NKTR Nektar Therapeutics | 0.23% | 2,475,954 | $2.3M | New |
| ALTISOURCE PORTFOLIO SOLNS S | 0.21% | 1,091,009 | $2.1M | Add +2.5% |
| TLPH Talphera Inc. | 0.20% | 1,992,519 | $2.1M | Add +61.0% |
| RNTX Rein Therapeutics Inc. filed as AILERON THERAPEUTICS INC | 0.17% | 255,000 | $1.7M | New |
| SRL Scully Royalty Ltd. | 0.15% | 239,197 | $1.5M | Reduce -1.4% |
| ANEB Anebulo Pharmaceuticals Inc. | 0.14% | 511,073 | $1.5M | No change |
| NEUROONE MED TECHNOLOGIES CO | 0.14% | 1,198,912 | $1.4M | Reduce -1.3% |
| PWP Perella Weinberg Partners | 0.14% | 99,778 | $1.4M | Reduce -35.9% |
| APRE Aprea Therapeutics Inc. | 0.14% | 205,760 | $1.4M | New |
| TIL Instil Bio Inc. | 0.14% | 127,292 | $1.4M | No change |
| KPRX Kiora Pharmaceuticals Inc. | 0.13% | 1,900,000 | $1.3M | New |
| FOSL Fossil Group Inc. | 0.13% | 1,306,338 | $1.3M | Add +222.3% |
| RILY BRC Group Holdings Inc. filed as B. RILEY FINANCIAL INC | 0.13% | 62,520 | $1.3M | No change |
| MTTR Matterport Inc. | 0.12% | 548,376 | $1.2M | New |
| SSKN Strata Skin Sciences Inc. | 0.12% | 3,089,821 | $1.2M | Reduce -1.2% |
| PLCE The Children's Place Inc. | 0.11% | 100,000 | $1.2M | New |
| SGRP Spar Group Inc. | 0.09% | 879,189 | $897K | No change |
| GOSS Gossamer Bio Inc. | 0.08% | 672,856 | $794K | No change |
| FBIO Fortress Biotech Inc. | 0.05% | 278,152 | $556K | Reduce -25.3% |
| PERF Perfect Corp. | 0.05% | 200,000 | $496K | New |
| EVOK Evoke Pharma Inc. | 0.04% | 675,000 | $412K | New |
| ANTX AN2 Therapeutics Inc. | 0.03% | 98,278 | $319K | Reduce -60.4% |
| LADR Ladder Capital Corp.-REIT | 0.03% | 25,631 | $285K | No change |
| EWTX Edgewise Therapeutics Inc. | 0.02% | 13,371 | $244K | New |
| APTOSE BIOSCIENCES INC | 0.01% | 88,540 | $147K | Reduce -26.3% |
| LUCD Lucid Diagnostics Inc. | 0.01% | 149,698 | $132K | No change |
| BMTX BM Technologies Inc. | 0.01% | 76,034 | $125K | No change |
| TACT Transact Technologies Inc. | 0.01% | 23,930 | $125K | Reduce -14.9% |
| XGN Exagen Inc. | 0.01% | 74,306 | $118K | Reduce -23.5% |
| RENALYTIX AI PLC-ADR | 0.01% | 117,644 | $101K | New |
| CUE Cue Biopharma Inc. | 0.01% | 26,692 | $50K | No change |
| GMDAQ Gamida Cell Ltd. | 0.00% | 800,000 | $29K | No change |
| KINTARA THERAPEUTICS INC | 0.00% | 12,763 | $1K | Reduce -42.0% |
| ARHS Arhaus Inc. | 0.00% | 1 | $15 | New |
Options reported separately and not counted above: IWM puts ($283.9M), XBI puts ($180.3M), LLY puts ($77.8M), LOPE puts ($54.5M), COST puts ($51.3M), ESTA calls ($28.0M), IYR puts ($27.0M), PTON calls ($10.3M), ENVA calls ($6.8M), HLF calls ($5.0M), ABEO calls ($3.8M), QURE calls ($1.3M).
Other holdings (5): bonds, preferreds, convertibles and warrants · $7.2M (not counted above)
| Security | Class | Shares / Principal | Value | Change |
|---|---|---|---|---|
| PAR TECHNOLOGY CORP (PAR 2.875 04/15/26) | NOTE 2.875% 4/1 · principal | 3,785,000 | $4.7M | No change |
| IMTXW Immatics NV -CW | *W EXP 07/01/202 | 558,977 | $1.5M | No change |
| CUTERA INC (CUTR 4 06/01/29) | NOTE 4.000% 6/0 · principal | 4,000,000 | $888K | No change |
| GFAIW Guardforce AI Co. Ltd. -CW26 | *W EXP 10/01/202 | 154,205 | $50K | No change |
| TCBWF TC Biopharm Holdings Ltd. | *W EXP 02/10/202 | 235,294 | $5K | No change |
Total filed on the 13F, all lines: $1.0B.
Portfolio Sells Q4 2023 → Q1 2024
| IWM iShares Russell 2000 ETF | Sold out | 0.00% | −1.98 |
| SLNO Soleno Therapeutics Inc. | Reduce -15.6% | 10.18% | −1.41 |
| LXFR Luxfer Holdings PLC | Reduce -62.1% | 0.70% | −0.93 |
| CYTK Cytokinetics Inc. | Sold out | 0.00% | −0.93 |
| AMLX Amylyx Pharmaceuticals Inc. | Sold out | 0.00% | −0.92 |
| SPRY Ars Pharmaceuticals Inc. | Sold out | 0.00% | −0.88 |
| IMTX Immatics NV | Reduce -44.3% | 0.82% | −0.68 |
| CASH Pathward Financial Inc. | Reduce -3.6% | 5.09% | −0.57 |
| IDYA Ideaya Biosciences Inc. | Sold out | 0.00% | −0.50 |
| ANTX AN2 Therapeutics Inc. | Reduce -60.4% | 0.03% | −0.48 |
| AYX Alteryx Inc. Class A | Sold out | 0.00% | −0.47 |
| MLKN Millerknoll Inc. | Sold out | 0.00% | −0.45 |
| LYRA Lyra Therapeutics Inc. | Reduce -30.4% | 1.73% | −0.41 |
| SRT Startek Inc. | Sold out | 0.00% | −0.35 |
| DNTH Dianthus Therapeutics Inc. | Sold out | 0.00% | −0.34 |
| RMR RMR Group Inc./the - A | Reduce -14.4% | 0.82% | −0.33 |
| RDVT Red Violet Inc. | Reduce -7.4% | 2.15% | −0.27 |
| TARS Tarsus Pharmaceuticals Inc. | Reduce -59.9% | 0.54% | −0.23 |
| GRPH Graphite Bio Inc. | Sold out | 0.00% | −0.22 |
| NPCE Neuropace Inc. | Reduce -33.7% | 1.01% | −0.21 |
| BVS Bioventus Inc. Class A | Reduce -2.9% | 2.98% | −0.20 |
| GDEN Golden Entertainment Inc. | Reduce -7.6% | 0.98% | −0.20 |
| DHX Dhi Group Inc. | Reduce -25.5% | 0.49% | −0.19 |
| JSPR Jasper Therapeutics Inc. | Sold out | 0.00% | −0.18 |
| RNAC Cartesian Therapeutics Inc. | Sold out | 0.00% | −0.16 |
| VTGN Vistagen Therapeutics Inc. | Reduce -16.5% | 0.79% | −0.15 |
| ILPT Industrial Logistics Propert | Reduce -5.6% | 0.80% | −0.15 |
| IMAX Imax Corp. | Reduce -8.5% | 3.52% | −0.13 |
| EAR Eargo Inc. | Sold out | 0.00% | −0.13 |
| CIDARA THERAPEUTICS INC COM NEW | Sold out | 0.00% | −0.12 |
| VMD Viemed Healthcare Inc. | Reduce -20.6% | 1.44% | −0.10 |
| NVNO Envveno Medical Corporation | Reduce -29.8% | 0.27% | −0.10 |
| SSKN Strata Skin Sciences Inc. | Reduce -1.2% | 0.12% | −0.06 |
| FBIO Fortress Biotech Inc. | Reduce -25.3% | 0.05% | −0.06 |
| OPTINOSE INC | Reduce -21.4% | 0.36% | −0.05 |
| PWP Perella Weinberg Partners | Reduce -35.9% | 0.14% | −0.05 |
| NEUROONE MED TECHNOLOGIES CO | Reduce -1.3% | 0.14% | −0.05 |
| SCTL Societal Cdmo Inc. | Sold out | 0.00% | −0.04 |
| SRTS Sensus Healthcare Inc. | Sold out | 0.00% | −0.04 |
| RDI Reading International Inc. Class A | Reduce -0.5% | 0.61% | −0.04 |
| APTOSE BIOSCIENCES INC | Reduce -26.3% | 0.01% | −0.02 |
| RFL Rafael Holdings Inc. Class B | Sold out | 0.00% | −0.01 |
| XGN Exagen Inc. | Reduce -23.5% | 0.01% | −0.01 |
| TACT Transact Technologies Inc. | Reduce -14.9% | 0.01% | −0.01 |
| CHECK CAP LTD | Sold out | 0.00% | −0.01 |
| SRL Scully Royalty Ltd. | Reduce -1.4% | 0.15% | −0.00 |
| KINTARA THERAPEUTICS INC | Reduce -42.0% | 0.00% | −0.00 |
| NNBR NN Inc. | Reduce -0.1% | 0.66% | +0.09 |
| MAX Mediaalpha Inc. Class A | Reduce -17.4% | 0.30% | +0.10 |
| CDXS Codexis Inc. | Reduce -2.9% | 1.54% | +0.12 |
Portfolio Buys Q4 2023 → Q1 2024
| DXPE DXP Enterprises Inc. | Add +33.7% | 1.43% | +0.74 |
| PTON Peloton Interactive Inc. Class A | Add +93.5% | 2.67% | +0.67 |
| EGRX Eagle Pharmaceuticals Inc. | New | 0.65% | +0.65 |
| RZLT Rezolute Inc. | Add +96.6% | 0.76% | +0.61 |
| ABEO Abeona Therapeutics Inc. | Add +2.7% | 1.65% | +0.52 |
| TRML Tourmaline Bio Inc. | Add +70.6% | 1.58% | +0.50 |
| ZYXIQ Zynex Inc. | Add +308.3% | 0.60% | +0.47 |
| SLN Silence Therapeutics PLC-ADR | New | 0.43% | +0.43 |
| CONNQ Conn's Inc. | Add +392.5% | 0.59% | +0.42 |
| MLYS Mineralys Therapeutics Inc. | New | 0.42% | +0.42 |
| NAMS Newamsterdam Pharma Co. NV | New | 0.41% | +0.41 |
| XBI SS SPDR S&P Biotech ETF | New | 0.39% | +0.39 |
| SVRA Savara Inc. | Add +75.9% | 0.85% | +0.39 |
| CLRB Cellectar Biosciences Inc. | Add +38.7% | 0.74% | +0.36 |
| MIST Milestone Pharmaceuticals Inc. | New | 0.31% | +0.31 |
| STKS One Group Hospitality Inc. | New | 0.30% | +0.30 |
| SNDX Syndax Pharmaceuticals Inc. | Add +27.4% | 1.09% | +0.30 |
| ACHV Achieve Life Sciences Inc. | New | 0.29% | +0.29 |
| EHTH Ehealth Inc. | Add +92.8% | 1.14% | +0.27 |
| NKTR Nektar Therapeutics | New | 0.23% | +0.23 |
| RNTX Rein Therapeutics Inc. | New | 0.17% | +0.17 |
| COGT Cogent Biosciences Inc. | Add +23.4% | 0.52% | +0.14 |
| AMRX Amneal Pharmaceuticals Inc. | Add +12.2% | 1.57% | +0.14 |
| ALTG Alta Equipment Group Inc. | Add +33.1% | 0.51% | +0.14 |
| APRE Aprea Therapeutics Inc. | New | 0.14% | +0.14 |
| KPRX Kiora Pharmaceuticals Inc. | New | 0.13% | +0.13 |
| MTTR Matterport Inc. | New | 0.12% | +0.12 |
| PLCE The Children's Place Inc. | New | 0.11% | +0.11 |
| TLPH Talphera Inc. | Add +61.0% | 0.20% | +0.11 |
| FOSL Fossil Group Inc. | Add +222.3% | 0.13% | +0.07 |
| ASSERTIO HOLDINGS INC | Add +21.7% | 0.88% | +0.06 |
| PERF Perfect Corp. | New | 0.05% | +0.05 |
| EVOK Evoke Pharma Inc. | New | 0.04% | +0.04 |
| EWTX Edgewise Therapeutics Inc. | New | 0.02% | +0.02 |
| RENALYTIX AI PLC-ADR | New | 0.01% | +0.01 |
| ARHS Arhaus Inc. | New | 0.00% | 0.00 |
| DRIO Dariohealth Corp. | Add +12.7% | 0.40% | −0.01 |
| PAYO Payoneer Global Inc. | Add +4.2% | 0.87% | −0.04 |
| ALTISOURCE PORTFOLIO SOLNS S | Add +2.5% | 0.21% | −0.17 |
| NDLS Noodles & Co. | Add +7.7% | 0.76% | −0.43 |
| QURE Uniqure NV | Add +4.4% | 1.58% | −0.43 |
Options Activity Q4 2023 → Q1 2024
| IWM iShares Russell 2000 ETF | put | Add +8.0% | 1,350,000 | $283.9M |
| XBI SS SPDR S&P Biotech ETF | put | Reduce -42.7% | 1,900,000 | $180.3M |
| LLY Eli Lilly & Co. | put | New | 100,000 | $77.8M |
| LOPE Grand Canyon Education Inc. | put | New | 400,000 | $54.5M |
| IYR iShares US Real Estate ETF | put | New | 300,000 | $27.0M |
| RH RH | call | Sold out | 40,000 | $11.7Mbefore exit |
| PTON Peloton Interactive Inc. Class A | call | Add +103.4% | 2,400,000 | $10.3M |
| HGV Hilton Grand Vacations Inc. | call | Sold out | 250,000 | $10.0Mbefore exit |
| ZM Zoom Communications Inc. | call | Sold out | 100,000 | $7.2Mbefore exit |
| HLF Herbalife Ltd. | call | Reduce -16.7% | 500,000 | $5.0M |
| SNDX Syndax Pharmaceuticals Inc. | call | Sold out | 200,000 | $4.3Mbefore exit |
| IMAX Imax Corp. | call | Sold out | 250,000 | $3.8Mbefore exit |
| EHTH Ehealth Inc. | call | Sold out | 250,000 | $2.2Mbefore exit |
| QURE Uniqure NV | call | Add +21.5% | 243,000 | $1.3M |
| TLPH Talphera Inc. | call | Sold out | 755,000 | $555Kbefore exit |
| KROS Keros Therapeutics Inc. | call | Sold out | 11,400 | $453Kbefore exit |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026Amended | 128 | $1.6B | TBBK, BVS, HGV, SVRA, ETON |
| Q1 2026 | 125 | $1.6B | TBBK, HGV, SLNO, BVS, PTON |
| Q4 2025 | 127 | $1.7B | TBBK, ESTA, HGV, SLNO, XTNT |
| Q3 2025 | 127 | $1.6B | ESTA, HGV, TBBK, QURE, SLNO |
| Q2 2025 | 133 | $1.4B | SLNO, HGV, ESTA, TBBK, XTNT |
| Q1 2025 | 126 | $1.2B | SLNO, HGV, ESTA, EOLS, TBBK |
| Q4 2024 | 118 | $1.4B | SLNO, ESTA, HGV, PTON, TBBK |
| Q3 2024 | 119 | $1.2B | SLNO, ESTA, BVS, PTON, EOLS |
| Q2 2024Amended | 113 | $994.2M | SLNO, ESTA, PTON, EOLS, BVS |
| Q1 2024 | 107 | $1.0B | SLNO, ESTA, CASH, EOLS, IMAX |